Danielle Leigh Forbes, TLMLP Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 221 E King St, Andover, KS 67002 Phone: 316-733-5047 |
Jenna Sue Fountain Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 221 E King St, Andover, KS 67002 Phone: 316-733-5047 |
Jill Roberts, LMLP Psychologist Medicare: Medicare Enrolled Practice Location: 217 W Ira Ct, Andover, KS 67002 Phone: 316-733-5047 |
Mr. John H Koppenhaver Iv, MA, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 217 W Ira Ct, Andover, KS 67002 Phone: 316-733-5047 Fax: 316-733-5060 |
Darci Elizabeth Klein, MS Psychologist Medicare: Medicare Enrolled Practice Location: 217 W Ira Ct, Andover, KS 67002 Phone: 316-733-5047 |
Jared Samuel Ohm, TLMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 217 W Ira Ct, Andover, KS 67002 Phone: 316-733-5047 |
Katherine Rayne Leahy, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 217 W Ira Ct, Andover, KS 67002 Phone: 316-733-5047 |
Mrs. Jennifer Lynn Blickenstaff, LCP Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 310 W Central Ave, Suite H, Andover, KS 67002 Phone: 316-733-9469 Fax: 316-733-8421 |
Lasheena Barnes, M.S. Psychologist Medicare: Medicare Enrolled Practice Location: 217 W Ira Ct, Andover, KS 67002 Phone: 316-775-5491 Fax: 316-337-5474 |
Dr. Sarah Pauline Watkins Mace, PH. D., ED. S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 245 Greenvalley Dr, Andover, KS 67002 Phone: 316-633-3059 |
News Archive
New findings from researchers at Georgetown University Medical Center in collaboration with Wake Forest University School of Medicine have shown that there is hope for individuals suffering a life-long history of reading problems.
Roche announced today the opening of a new state-of-the-art clinical supply manufacturing facility on its campus in Nutley, N.J. The Roche Center of Excellence produces dosage forms of highly potent compounds for preclinical safety studies, and Phase 1 and 2 clinical studies.
In a recent study published on the pre-print bioRxiv* server, a group of Israeli researchers discusses their progress towards developing an oral multi-antigen SARS-CoV-2 vaccine.
In recent years, scientists have introduced us to a paradigm shift in the microscopic world. We've moved from thinking about all bacteria as bad guys to be wiped out with antibiotics and hand sanitizer to recognizing that some microbes are helpers, good bacteria that live in our GI tract (and all over our bodies) that keep us healthy.
› Verified 2 days ago